Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Gabriella Montes

ID: 1b83a3ed-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Genentech and Samsung Bioepis Settle Bevacizumab Biosimilar Patent Dispute

Big Molecule Watch · September 15, 2022

Sandoz Announces New Global ‘Act4Biosimilars’ Initiative, to Improve Patient Access and Increase Adoption by At Least 30% in 30+ Countries by 2030

Big Molecule Watch · June 7, 2022

Samsung Biologics Completes Full Acquisition of Samsung Bioepis

Big Molecule Watch · April 26, 2022

OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico

Big Molecule Watch · March 23, 2022

FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA (Adalimumab) Biosimilar Candidate

Big Molecule Watch · January 11, 2022

Previous

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog